TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 50 filers reported holding TALARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,742 | -7.6% | 5,602 | 0.0% | 0.00% | – |
| Q2 2023 | $17,030 | -18.2% | 5,602 | -49.4% | 0.00% | – |
| Q1 2023 | $20,826 | +1651.6% | 11,078 | +850.1% | 0.00% | – |
| Q4 2022 | $1,189 | +18.9% | 1,166 | +111.2% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 552 | +360.0% | 0.00% | – |
| Q2 2022 | $1,000 | -80.0% | 120 | -77.9% | 0.00% | – |
| Q1 2022 | $5,000 | -87.8% | 542 | -79.9% | 0.00% | – |
| Q4 2021 | $41,000 | -95.0% | 2,700 | -95.5% | 0.00% | – |
| Q3 2021 | $814,000 | -7.6% | 60,000 | 0.0% | 0.00% | – |
| Q2 2021 | $881,000 | – | 60,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $7,713,000 | 11.20% |
| Aisling Capital Management LP | 175,000 | $460,000 | 0.30% |
| Artal Group S.A. | 2,064,262 | $5,429,000 | 0.23% |
| Cormorant Asset Management, LP | 900,649 | $2,369,000 | 0.17% |
| Eventide Asset Management | 1,561,092 | $4,106,000 | 0.08% |
| Blackstone Inc. | 8,089,315 | $21,275 | 0.08% |
| Logos Global Management LP | 197,913 | $521,000 | 0.06% |
| Values First Advisors, Inc. | 30,715 | $81,000 | 0.06% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $8,652,000 | 0.04% |
| CAAS CAPITAL MANAGEMENT LP | 297,707 | $783,000 | 0.04% |